ICH is evaluating RIZE Massachusetts’ inaugural grant program, which seeks to increase access to treatment for opioid use disorder among vulnerable populations.
ICH conducted qualitative patient interviews to inform the design of disease management programs for chronic obstructive pulmonary disease, congestive heart failure, diabetes, opioid use disorder, and chronic pain at Cambridge Health Alliance.
ICH administered a survey to local police departments about Crisis Intervention Team programs.
ICH is the evaluator for SUSTAIN Communities, an initiative aiming to build community health center capacity to treat opioid use disorder.
ICH is using electronic medical records data to examine prescription opioid use and addiction among a primary care population of youth and young adults in an urban safety-net setting.
ICH evaluated Cambridge Health Alliance’s primary care behavioral health integration program, a complex intervention aimed at building capacity to treat mental health conditions and substance use disorders within 12 primary care clinics.